In-Vitro Diagnostics Market: Current Scenario and Forecast (2019-2025)

In-Vitro Diagnostics Market: Current Scenario and Forecast (2019-2025)

Emphasis on Product (Reagents, Instruments Services), Techniques (Immunoassay, Clinical Chemistry, SMBG, Molecular Diagnostics, Hematology, Microbiology, Point-of-Care, Hemostasis), Application (Infectious Disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disease, Others), End-Users (Hospitals, Clinics & Labs, Home Care, Others), Usability (Disposable IVD Devices, Reusable IVD Devices) and Region/Country

$ 3500
$4900
$6860

Published: Dec-2019

Pages:401

Table:96

Figure:278

Report ID:UMHE19192

Global In-Vitro Diagnostics Market was valued at US$ 68.92 billion in 2018 and is anticipated to reach US$ 98.18 billion by 2025 displaying a reasonable CAGR of 5.24% over the forecast period (2019-2025). Global In-Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to detect infection, diagnose a medical condition, prevent disease and monitor drug therapies. The market of In-Vitro Diagnostics market is anticipated to grow enormously owing to factors such as rising geriatric population, increasing prevalence of chronic diseases, increasing adoption of Point-of-care diagnosis, and technology advancement in the In-Vitro Diagnostics technology. Rising demand for Point-of-Care (POC) devices is expected to fuel the market growth in near future. In addition, introduction of advanced technologies, such as biochips and nano-biotechnology, and miniaturization of microfluidics are expected to increase the demand for PoC products. These advancements have enabled easy access to PoC diagnostic tests and are likely to facilitate quick and effective test results, thereby boosting the overall market growth. The changing reimbursement models and regulations, investing in unifying technology would mark as a trend in this industry. However, stringent government regulations for the manufacturing of IVD products will act as the major challenges in the growth of this market.

Factors Influencing IVD Companies’ Business Models

“Reagents dominated the product segment of the global In-Vitro Diagnostics market with 69.0% share in 2018”

Based on Product type the global in-vitro diagnostics market is segmented into reagents and Instruments Services. The market of the Reagents segment is expected to grow tremendously and is projected to dominate the market in 2025 due to its high demand in over-the-counter diagnostic tests, paired with rising demand of these for tests at non-medical facilities such as home.

“Immunoassay technique of In-Vitro Diagnostic dominated the market in 2018”

Based on techniques the global In-Vitro Diagnostics market is segmented into Immunoassay, Clinical Chemistry, SMBG, Molecular Diagnostics, Hematology, Microbiology, Point-of-Care and Hemostasis. The Immunoassay technique occupied the largest share of 24.7% in 2018 and is expected to maintain its dominance throughout the forecast period 2019-2025. However, Molecular Diagnostics and Point-of-Care testing techniques are expected to witness highest CAGR growth during the analyzed period, owing to increasing demand for such tests at home.

“In-Vitro Diagnostic technology was majorly applied for the treatment or diagnosis of Infectious Disease”

Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases are the major applications of In-Vitro Diagnostics technology. In 2018, IVD was majorly used for the treatment and diagnosis of Infectious Diseases. The segment is expected to witness CAGR 4.89% during the forecast period 2019-2025 to generate revenue of US$ 33.73 billion by 2025. However, Oncology treatment using IVD is expected to grow at the highest rate during the analyzed period.

In-Vitro Diagnostics Market Size, by Application, Global, 2018-25 (US$ Bn)

“Hospitals were the major end-users of In-Vitro Diagnostic technology in 2018”

Based on end-users, the global In-Vitro Diagnostics market is bifurcated into hospitals, clinics & labs, home care and other healthcare facilities. In 2018, hospital segment occupied 47.6% share. However, use of the technology for home disease treatment is expected to witness highest CAGR growth dusting the forecast period 2019-2025. The growing elderly population and associated diseases would help the segment to witness such growth.

“Reusable IVD Devices are expected to dominate the usability segment of the global in-vitro diagnostics market during the analyzed period.”

In-Vitro Diagnostics market segmented based on usability include reusable and disposable IVD devices. The Reusable IVD Devices occupied the largest share and is expected to maintain its dominance throughout the forecast period 2019-2025.

“North America represents one of the largest markets of In-Vitro Diagnostics market globally in 2018”

For a deep-dive analysis of the industry and its adoption rate, detailed regional/country-level analysis was conducted for regions including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, UK and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of the World (Brazil and Others). In 2018, North America dominated the market, however growing elderly population in Europe and Asia-Pacific would help the region to use more of in-vitro diagnostic technology for disease detection and treatment.

Competitive Landscape-Top 10 Market Players

Abbott Laboratories, Becton Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Johnson & Johnson, Roche, Siemens Healthineers AG, Sysmex Corporation and Thermo Fisher Scientific are some of the prominent players operating in the Global In-Vitro Diagnostics market industry. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products in the In-Vitro Diagnostic sector.

Reasons to buy (The research report presents):

  • Current and future market size from 2018 to 2025 in terms of value (US$)
  • Combined analysis of deep-dive secondary research and input from primary research through Key Opinion Leaders of the industry
  • Country-level details of the overall adoption of the In-Vitro Diagnostics market
  • A quick review of overall industry performance at a glance
  • In-depth analysis of key industry players
  • A detailed analysis of regulatory framework, drivers, restraints, key trends and opportunities prevailing in the industry
  • Examination of industry attractiveness with the help of Porter’s Five Forces analysis and start-ups
  • The study comprehensively covers the market across different segments and sub-segments of the technology
  • Region/country Covered: North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, UK and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of the World (Brazil and Others)

Customization Options:

The Global In-Vitro Diagnostics Market can be customized to the country level or any other market segment. Besides this, UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients.

    1.1 Market Definition
    1.2 Objective of the Study
    1.3 Limitation  
    1.4 Stakeholders  
    1.5 Currency used in the Report
    1.6 Scope of the Global In-Vitro Diagnostics Market Study
  2 RESEARCH METHODOLOGY
    2.1 Research Methodology for Global In-Vitro Diagnostics Market Study
      2.1.1 Main objective of the Global In-Vitro Diagnostics Market Study
  3 COMPREHENSIVE ASSESSMENT OF THE VALUE OF DIAGNOSTIC TESTS
    3.1 General Overview
    3.2 Capturing the full spectrum of the value that a diagnostic test contributes
    3.3 Ensuring that robust analyses underpin the value assessment
    3.4 Accounting for variation in diagnostic test types in value assessment methods
    3.5 Aligning on how to define and measure value drivers
      3.5.1 Value Driver: Clinical Impact
      3.5.2 Value Driver: Non-Clinical Patient Impact
      3.5.3 Value Driver: Care Delivery Revenue and Cost Impact
      3.5.4 Value Driver: Public/Population Impact
  4 REFRAMING THE DIAGNOSTICS INDUSTRY
    4.1 General Overview
    4.2 The key to accountable adoption of in vitro diagnostic technologies
      4.2.1 Drivers of diagnostic technology innovation and adoption:
      4.2.2 Current Challenges for Diagnostic Innovation
        4.2.2.1 Regulation
        4.2.2.2 Evidence generation
        4.2.2.3 Clinical needs
        4.2.2.4 Commissioning
        4.2.2.5 Adoption
      4.2.3 Current needs
        4.2.3.1 Three key questions for diagnostic innovation:
      4.2.4 Developing an evidence ‘toolkit’ for diagnostic test research
    4.3 Value of Diagnostics to Health Care and Health Status
  5 COSTS AND BENEFITS OF DIAGNOSTIC TESTING
    5.1 General Overview
    5.2 Introduction and problem statement
      5.2.1 Increasing healthcare costs
      5.2.2 Underutilization of IVDs in clinical practice
    5.3 Consequences for patient care
      5.3.1 Conceptual interventions
        5.3.1.1 Fostering prevention, screening, early diagnosis, and therapy
        5.3.1.2 Promoting comprehensive disease management
        5.3.1.3 Promoting stratified disease management
        5.3.1.4 Targeted delivery of treatment alongside companion diagnostics
    5.4 Consequences for policies: promoting a fee for outcomes
    5.5 Analysis    
    5.6 Conclusion  
  6 RISK MITIGATION  
    6.1 General Overview
    6.2 Supply Chain  
    6.3 Risk Assessment
    6.4 Bulk, Custom and Contract Manufacturing
  7 CURRENT AND FUTURE USE OF DIAGNOSTIC PRODUCTS
    7.1 Primary Uses of Diagnostics
      7.1.1 Predictive Applications/Screening/Early Disease Detection
      7.1.2 Diagnostic
      7.1.3 Secondary Risk Assessment – Prognostic
      7.1.4 Drug Selection/Treatment Targeting
      7.1.5 Disease/Condition Monitoring and Management
    7.2 In Vitro Diagnostics: Overview of Future Trends and Directions
      7.2.1 Predict Disease Before Symptoms Appear
      7.2.2 Predict Beneficial and Adverse Treatment Effects
      7.2.3 Enable Personalized “Real-Time” Treatment and Disease Management Regimens
      7.2.4 Facilitate Point-of-care and Near-patient Testing
      7.2.5 Enable Home Testing
      7.2.6 Public Health, Environmental, Bioterrorism Applications
      7.2.7 Technology and Testing System Integration
    7.3 The importance of diagnostics
      7.3.1 The role of diagnostics
      7.3.2 Improving patient care
      7.3.3 Reducing healthcare spending
      7.3.4 Reasons In Vitro Diagnostics Are Superior
        7.3.4.1 Quick Results
        7.3.4.2 Multiple Tests at the Same Time
        7.3.4.3 Customizable to Detect Different Chemicals
        7.3.4.4 Ease of Recording the Data
        7.3.4.5 Reliable Results That Can Be Quickly Repeated
  8 EXECUTIVE SUMMARY
  9 INDUSTRY PERFORMANCE
  10 MARKET OVERVIEW  
    10.1 Introduction of In-Vitro Diagnostics Market
      10.1.1 Essential Components or Attributes of Diagnostics
      10.1.2 Main Categories of Diagnostics
      10.1.3 Settings of Use
    10.2 Market Dynamics
      10.2.1 Market Drivers
        10.2.1.1 Increasing prevalence of Chronic Diseases
        10.2.1.2 Rising geriatric population
        10.2.1.3 Increasing adoption of Point-of-Care Diagnosis
        10.2.1.4 Technology Advancement in the In-vitro Diagnostics
      10.2.2 Market Restraints
        10.2.2.1 Stringent Government Regulations for the Manufacturing of IVD Products
        10.2.2.2 Unfavourable Reimbursement Policies for In-vitro Diagnostics
      10.2.3 Market Opportunities
        10.2.3.1 Development of Condition-Specific Markers and Tests
        10.2.3.2 Growing significance of Companion Diagnostics
      10.2.4 Market Trends
        10.2.4.1 Changing Reimbursement Models and Regulations
        10.2.4.2 Investing in Unifying Technology
        10.2.4.3 Consolidation and Automation of Labs
        10.2.4.4 Shift to data-driven Healthcare
        10.2.4.5 Consumer Lab Testing
        10.2.4.6 Healthcare Convergence
  11 REGULATIONS AND REIMBURSEMENT POLICY
    11.1 United States  
    11.2 Europe    
    11.3 China    
    11.4 India    
    11.5 Japan    
    11.6 Australia    
  12 KEY MARKET INDICATORS
    12.1 Demand Side Analysis
      12.1.1 Key Facts on Aging Population
      12.1.2 Health Conditions Associated with Aging
        12.1.2.1 Some of the key facts about Cardiovascular Diseases (CVD)
    12.2 Supply Side Analysis
      12.2.1 Product Launches
      12.2.2 Partnerships
      12.2.3 Business Expansion and Investments
      12.2.4 Mergers and Acquisitions
      12.2.5 SWOT Analysis of In-Vitro Diagnostics Market
      12.2.6 Value Chain Analysis of In-Vitro Diagnostics
  13 ROLE OF IN-VITRO DIAGNOSTICS IN HEALTHCARE
    13.1 General Overview
  14 MARKET INSIGHT BY PRODUCT
    14.1 General Overview
      14.1.1 Reagents  
      14.1.2 Instruments Services
  15 MARKET INSIGHT BY TECHNIQUES
    15.1 General Overview
      15.1.1 Immunoassay
      15.1.2 Clinical Chemistry
      15.1.3 Self-Monitoring of Blood Glucose (SMBG)
      15.1.4 Molecular Diagnostics
      15.1.5 Hematology
      15.1.6 Microbiology
      15.1.7 Point-of-Care
      15.1.8 Hemostasis
  16 MARKET INSIGHT BY APPLICATION
    16.1 General Overview
      16.1.1 Infectious Disease
      16.1.2 Diabetes  
      16.1.3 Oncology  
      16.1.4 Cardiology
      16.1.5 Nephrology
      16.1.6 Autoimmune Disease
      16.1.7 Others  
  17 MARKET INSIGHT BY END-USER
    17.1 General Overview
      17.1.1 Hospital In-Vitro Diagnostic
      17.1.2 Clinics & Laboratory In-Vitro Diagnostic
      17.1.3 Home Care In-Vitro Diagnostic Market
      17.1.4 Others Healthcare Facility In-Vitro Diagnostic
  18 MARKET INSIGHT BY USABILITY
    18.1 General Overview
      18.1.1 Disposable IVD Devices
      18.1.2 Reusable IVD Devices
  19 MARKET INSIGHT BY REGION
    19.1 General Overview
    19.2 North America IVD Market Insight
      19.2.1 North America In-Vitro Diagnostics Market by Product
      19.2.2 North America In-Vitro Diagnostics Market by Technique
      19.2.3 North America In-Vitro Diagnostics Market by Application
      19.2.4 North America In-Vitro Diagnostics Market by End-Users
      19.2.5 North America In-Vitro Diagnostics Market by Usability
      19.2.6 North America In-Vitro Diagnostics Market by Country
        19.2.6.1 United States
          19.2.6.1.1 Key Findings on Healthcare Spending in the US, 2017
          19.2.6.1.2 US Health Spending by Type of Service or Product, 2017
          19.2.6.1.3 Health Spending by Major Sources of Funds
          19.2.6.1.4 United States In-Vitro Diagnostics Market by Product
          19.2.6.1.5 United States In-Vitro Diagnostics Market by Technique
          19.2.6.1.6 United States In-Vitro Diagnostics Market by Application
          19.2.6.1.7 United States In-Vitro Diagnostics Market by End-Users
          19.2.6.1.8 United States In-Vitro Diagnostics Market by Usability
        19.2.6.2 Canada
          19.2.6.2.1 Key Findings on Canada Healthcare Spending, 2018
          19.2.6.2.2 Key Findings on Hospital sector Spending in Canada, 2017
          19.2.6.2.3 Canada In-Vitro Diagnostics Market by Product
          19.2.6.2.4 Canada In-Vitro Diagnostics Market by Technique
          19.2.6.2.5 Canada In-Vitro Diagnostics Market by Application
          19.2.6.2.6 Canada In-Vitro Diagnostics Market by End-Users
          19.2.6.2.7 Canada In-Vitro Diagnostics Market by Usability
        19.2.6.3 Rest of North America
          19.2.6.3.1 Rest of NA In-Vitro Diagnostics Market by Product
          19.2.6.3.2 Rest of NA In-Vitro Diagnostics Market by Technique
          19.2.6.3.3 Rest of NA In-Vitro Diagnostics Market by Application
          19.2.6.3.4 Rest of NA In-Vitro Diagnostics Market by End-Users
          19.2.6.3.5 Rest of NA In-Vitro Diagnostics Market by Usability
    19.3 Europe IVD Market Insight
      19.3.1 Europe In-Vitro Diagnostics Market by Product
      19.3.2 Europe In-Vitro Diagnostics Market by Technique
      19.3.3 Europe In-Vitro Diagnostics Market by Application
      19.3.4 Europe In-Vitro Diagnostics Market by End-Users
      19.3.5 Europe In-Vitro Diagnostics Market by Usability
      19.3.6 Europe In-Vitro Diagnostics Market by Country
        19.3.6.1 Germany
          19.3.6.1.1 Germany In-Vitro Diagnostics Market by Product
          19.3.6.1.2 Germany In-Vitro Diagnostics Market by Technique
          19.3.6.1.3 Germany In-Vitro Diagnostics Market by Application
          19.3.6.1.4 Germany In-Vitro Diagnostics Market by End-Users
          19.3.6.1.5 Germany In-Vitro Diagnostics Market by Usability
        19.3.6.2 France
          19.3.6.2.1 France In-Vitro Diagnostics Market by Product
          19.3.6.2.2 France In-Vitro Diagnostics Market by Technique
          19.3.6.2.3 France In-Vitro Diagnostics Market by Application
          19.3.6.2.4 France In-Vitro Diagnostics Market by End-Users
          19.3.6.2.5 France In-Vitro Diagnostics Market by Usability
        19.3.6.3 Spain
          19.3.6.3.1 Spain In-Vitro Diagnostics Market by Product
          19.3.6.3.2 Spain In-Vitro Diagnostics Market by Technique
          19.3.6.3.3 Spain In-Vitro Diagnostics Market by Application
          19.3.6.3.4 Spain In-Vitro Diagnostics Market by End-Users
          19.3.6.3.5 Spain In-Vitro Diagnostics Market by Usability
        19.3.6.4 Italy  
          19.3.6.4.1 Italy In-Vitro Diagnostics Market by Product
          19.3.6.4.2 Italy In-Vitro Diagnostics Market by Technique
          19.3.6.4.3 Italy In-Vitro Diagnostics Market by Application
          19.3.6.4.4 Italy In-Vitro Diagnostics Market by End-Users
          19.3.6.4.5 Italy In-Vitro Diagnostics Market by Usability
        19.3.6.5 United Kingdom
          19.3.6.5.1 United Kingdom In-Vitro Diagnostics Market by Product
          19.3.6.5.2 United Kingdom In-Vitro Diagnostics Market by Technique
          19.3.6.5.3 United Kingdom In-Vitro Diagnostics Market by Application
          19.3.6.5.4 United Kingdom In-Vitro Diagnostics Market by End-Users
          19.3.6.5.5 United Kingdom In-Vitro Diagnostics Market by Usability
        19.3.6.6 Rest of Europe
          19.3.6.6.1 Rest of Europe In-Vitro Diagnostics Market by Product
          19.3.6.6.2 Rest of Europe In-Vitro Diagnostics Market by Technique
          19.3.6.6.3 Rest of Europe In-Vitro Diagnostics Market by Application
          19.3.6.6.4 Rest of Europe In-Vitro Diagnostics Market by End-Users
          19.3.6.6.5 Rest of Europe In-Vitro Diagnostics Market by Usability
    19.4 Asia-Pacific In-Vitro Diagnostics Market Insight
      19.4.1 Asia-Pacific In-Vitro Diagnostics Market by Product
      19.4.2 Asia-Pacific In-Vitro Diagnostics Market by Technique
      19.4.3 Asia-Pacific In-Vitro Diagnostics Market by Application
      19.4.4 Asia-Pacific In-Vitro Diagnostics Market by End-Users
      19.4.5 Asia-Pacific In-Vitro Diagnostics Market by Usability
      19.4.6 Asia-Pacific In-Vitro Diagnostics Market by Country
        19.4.6.1 China
          19.4.6.1.1 IVD Product Registration in China
          19.4.6.1.2 China IVD Type Testing Process
          19.4.6.1.3 Clinical Trials for IVD Products in China
          19.4.6.1.4 Reimbursement of IVD Products in China
          19.4.6.1.5 China In-Vitro Diagnostics Market by Product
          19.4.6.1.6 China In-Vitro Diagnostics Market by Technique
          19.4.6.1.7 China In-Vitro Diagnostics Market by Application
          19.4.6.1.8 China In-Vitro Diagnostics Market by End-Users
          19.4.6.1.9 China In-Vitro Diagnostics Market by Usability
        19.4.6.2 India
          19.4.6.2.1 Notified Medical Devices
          19.4.6.2.2 Non-Notified Medical Devices
          19.4.6.2.3 India In-Vitro Diagnostics Market by Product
          19.4.6.2.4 India In-Vitro Diagnostics Market by Technique
          19.4.6.2.5 India In-Vitro Diagnostics Market by Application
          19.4.6.2.6 India In-Vitro Diagnostics Market by End-Users
          19.4.6.2.7 India In-Vitro Diagnostics Market by Usability
        19.4.6.3 Japan
          19.4.6.3.1 Classification of IVDs in Japan
          19.4.6.3.2 Category of Approval Applications for IVD Reagents
          19.4.6.3.3 Japan In-Vitro Diagnostics Market by Product
          19.4.6.3.4 Japan In-Vitro Diagnostics Market by Technique
          19.4.6.3.5 Japan In-Vitro Diagnostics Market by Application
          19.4.6.3.6 Japan In-Vitro Diagnostics Market by End-Users
          19.4.6.3.7 Japan In-Vitro Diagnostics Market by Usability
        19.4.6.4 Australia
          19.4.6.4.1 Australia In-Vitro Diagnostics Market by Product
          19.4.6.4.2 Australia In-Vitro Diagnostics Market by Technique
          19.4.6.4.3 Australia In-Vitro Diagnostics Market by Application
          19.4.6.4.4 Australia In-Vitro Diagnostics Market by End-Users
          19.4.6.4.5 Australia In-Vitro Diagnostics Market by Usability
        19.4.6.5 Rest of Asia-Pacific Market Insight
          19.4.6.5.1 Rest of APAC In-Vitro Diagnostics Market by Product
          19.4.6.5.2 Rest of APAC In-Vitro Diagnostics Market by Technique
          19.4.6.5.3 Rest of APAC In-Vitro Diagnostics Market by Application
          19.4.6.5.4 Rest of APAC In-Vitro Diagnostics Market by End-Users
          19.4.6.5.5 Rest of APAC In-Vitro Diagnostics Market by Usability
    19.5 Rest of World Market Insight
      19.5.1 Rest of World In-Vitro Diagnostics Market by Product
      19.5.2 Rest of World In-Vitro Diagnostics Market by Technique
      19.5.3 Rest of World In-Vitro Diagnostics Market by Application
      19.5.4 Rest of World In-Vitro Diagnostics Market by End-Users
      19.5.5 Rest of World In-Vitro Diagnostics Market by Usability
      19.5.6 Rest of World In-Vitro Diagnostics Market by Country
        19.5.6.1 Brazil
          19.5.6.1.1 Brazil In-Vitro Diagnostics Market by Product
          19.5.6.1.2 Brazil In-Vitro Diagnostics Market by Technique
          19.5.6.1.3 Brazil In-Vitro Diagnostics Market by Application
          19.5.6.1.4 Brazil In-Vitro Diagnostics Market by End-Users
          19.5.6.1.5 Brazil In-Vitro Diagnostics Market by Usability
        19.5.6.2 Other Rest of World
          19.5.6.2.1 Other Rest of World In-Vitro Diagnostics Market by Product
          19.5.6.2.2 Other Rest of World In-Vitro Diagnostics Market by Technique
          19.5.6.2.3 Other Rest of World In-Vitro Diagnostics Market by Application
          19.5.6.2.4 Other Rest of World In-Vitro Diagnostics Market by End-Users
          19.5.6.2.5 Other Rest of World In-Vitro Diagnostics Market by Usability
  20 COMPETITIVE SCENARIO
    20.1 Porter’s Five forces analysis
      20.1.1 Bargaining Power of Suppliers
      20.1.2 Bargaining Power of Buyers
      20.1.3 Threat of New Entrants
      20.1.4 Threat of Substitutes
      20.1.5 Industry Rivalry
    20.2 Market Share Analysis, by Company
      20.2.1 Global In-Vitro Diagnostic Market Share Analysis, by Company 2018
  21 TOP COMPANY PROFILES
    21.1 Abbott Laboratories
      21.1.1 Key Facts  
      21.1.2 Business Description
      21.1.3 Key Product/Services Offerings
      21.1.4 Growth Strategy
      21.1.5 SWOT Analysis
      21.1.6 Key Financials
        21.1.6.1 Revenue Split
      21.1.7 Recent Developments
        21.1.7.1 Product Launches
        21.1.7.2 Partnership
        21.1.7.3 Merger and Acquisition
    21.2 Becton Dickinson
      21.2.1 Key Facts  
      21.2.2 Business Description
      21.2.3 Key Product/Services Offerings (AI Technology)
      21.2.4 Growth Strategy
      21.2.5 SWOT Analysis
      21.2.6 Key Financials
        21.2.6.1 Revenue Split
      21.2.7 Recent Developments
        21.2.7.1 Product Launch
        21.2.7.2 Partnerships
        21.2.7.3 Business Expansions and Investments
        21.2.7.4 Merger & Acquisitions
    21.3 Biomérieux SA  
      21.3.1 Key Facts  
      21.3.2 Business Description
      21.3.3 Key Product/Services Offerings
      21.3.4 Growth Strategy
      21.3.5 SWOT Analysis
      21.3.6 Key Financials
        21.3.6.1 Revenue Split
      21.3.7 Recent Developments
        21.3.7.1 Product Launches
        21.3.7.2 Partnerships
        21.3.7.3 Mergers and Acquisitions
    21.4 Bio-Rad Laboratories, Inc.
      21.4.1 Key Facts  
      21.4.2 Business Description
      21.4.3 Key Product/Services Offerings
      21.4.4 Growth Strategy
      21.4.5 SWOT Analysis
      21.4.6 Key Financials
        21.4.6.1 Revenue Split
      21.4.7 Recent Developments
        21.4.7.1 Product Launches
        21.4.7.2 Mergers and Acquisitions
    21.5 Danaher Corporation
      21.5.1 Key Facts  
      21.5.2 Business Description
      21.5.3 Key Product/Services Offerings
      21.5.4 Growth Strategy
      21.5.5 SWOT Analysis
      21.5.6 Key Financials
        21.5.6.1 Revenue Split
      21.5.7 Recent Developments
        21.5.7.1 Merger and Acquisitions
    21.6 Johnson & Johnson
      21.6.1 Key Facts  
      21.6.2 Business Description
      21.6.3 Key Product/Services Offerings
      21.6.4 Growth Strategy
      21.6.5 SWOT Analysis
      21.6.6 Key Financials
        21.6.6.1 Revenue Split
    21.7 Roche Holding AG
      21.7.1 Key Facts  
      21.7.2 Business Description
      21.7.3 Key Product/Services Offerings
      21.7.4 Growth Strategy
      21.7.5 SWOT Analysis
      21.7.6 Key Financials
        21.7.6.1 Revenue Split
      21.7.7 Recent Developments
        21.7.7.1 Product Launches
        21.7.7.2 Partnership
        21.7.7.3 Mergers and Acquisitions
    21.8 Siemens Healthineers AG.
      21.8.1 Key Facts  
      21.8.2 Business Description
      21.8.3 Key Product/Services Offerings
      21.8.4 Growth Strategy
      21.8.5 SWOT Analysis
      21.8.6 Key Financials
        21.8.6.1 Revenue Split
      21.8.7 Recent Developments
        21.8.7.1 Product Launches
        21.8.7.2 Partnership
        21.8.7.3 Business Expansion and Investment
        21.8.7.4 Merger and Acquisitions
    21.9 Thermo Fisher Scientific
      21.9.1 Key Facts  
      21.9.2 Business Description
      21.9.3 Key Product/Services Offerings
      21.9.4 Growth Strategy
      21.9.5 SWOT Analysis
      21.9.6 Key Financials
        21.9.6.1 Revenue Split
      21.9.7 Recent Developments
        21.9.7.1 Product Launch
        21.9.7.2 Partnerships
        21.9.7.3 Business Expansion and Investment
        21.9.7.4 Merger and Acquisition
    21.10 Sysmex Corporation
      21.10.1 Key Facts  
      21.10.2 Business Description
      21.10.3 Key Product/Services Offerings
      21.10.4 SWOT Analysis
      21.10.5 Growth Strategy
      21.10.6 Key Financials
        21.10.6.1 Revenue Split
      21.10.7 Recent Developments
        21.10.7.1 Product Launches
        21.10.7.2 Partnership
        21.10.7.3 Business Expansion & Investments
        21.10.7.4 Merger and Acquisitions

Analyzing historical market, estimation of the current market and forecasting the future market for Global In-Vitro Diagnostics were the three major steps undertaken to create and analyze the overall adoption of in-vitro diagnostic services in major regions/countries. Exhaustive secondary research was conducted to collect the historical market of the technology and overall estimation of the current market. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted with industry experts across value chain of the In-Vitro Diagnostics technology. Post assumption and validation of market numbers through primary interviews, top-down approach was employed to forecast the complete market size of In-Vitro Diagnostics market globally. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the overall market size of segments and sub-segments of the technology. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the Global In-Vitro Diagnostics Market through company internal sources such as annual report & financial statements, performance presentations, press releases, inventory records, etc. and external sources including trade journals, news & articles, government publications, economic data, competitor publications, sector reports, regulatory bodies publications, safety standard organizations, third-party database and other credible publications. For economic data collection, sources such as World Bank, CDC, European Commission (EC), United Nations and WHO, OECD among others were used.

Step 2: Market Segmentation:

After obtaining the historical market size of the overall market, detailed secondary analysis was conducted to gather historical market insights and share for different segments and sub-segments of the Global In-Vitro Diagnostics technology. Major segments included in the report are product, techniques, applications, end-users and usability.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments detailed factor analysis was conducted to estimate the current market size of the Global In-Vitro Diagnostics technology. Factor analysis was conducted using dependent and independent variables such as accelerating aging population, rising prevalence of age-related disorders and Increasing demand for residential care facilities. Historical trends of the Global In-Vitro Diagnostics technology and their year-on-year impact on the market size and share in the recent past were analyzed. The demand and supply-side scenario were also thoroughly studied.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at current market size, key players in major applications and markets, market shares of these players and industry’s supply chain. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weightage was assigned to different factors including market drivers, restraints, opportunities and trends. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up/Top-down was applied to arrive at the market forecast pertaining to 2025 for different segments and sub-segments of the technology. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value and rate of adoption of In-Vitro Diagnostics globally
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in major applications and markets as well as the market share of each player. Also, the growth strategies adopted by these players to compete in the ever-growing Global In-Vitro Diagnostics market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, etc.). Primary research findings were summarised, and statistical analysis was performed to prove the stated hypothesis. Input from primary research was consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants

Market Engineering

Data triangulation technique was employed to complete the overall market engineering process and to arrive precise statistical numbers of each segment and sub-segment pertaining to the Global In-Vitro Diagnostics market. Data was split into several segments post studying various parameters and trends in areas such as product, techniques, applications, end-user, usability and regions such as North America, Europe, Asia-Pacific and Rest of the World.

Main objective of the In-Vitro Diagnostics Market Study

The current & future market trends of the Global In-Vitro Diagnostics market are pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market, providing a platform for the industrial participant to exploit the untapped market to benefit as first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the global in-vitro diagnostics market in terms of value (US$)
  • Analyze the current and forecast market size of different segments and sub-segments of the global in-vitro diagnostics market
  • To analyze the revenue and business models of the market players in the industry
  • To understand the initiatives undertaken by diagnostics companies Vs. service providers to increase the overall analysis of in-vitro diagnostics in major regions
  • Define and describe the segments and sub-segments considered in the evaluation of the global in-vitro diagnostics market and anticipate potential risk associated with the market
  • Define and analysis of the government regulations for diagnostics
  • Analyze the current and forecast market size of the global in-vitro diagnostics market for major regions/countries including North America (US, Canada, Rest of North of America), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific) and Rest of World (Brazil, Others)

Define and analyze the competitive landscape of the global in-vitro diagnostics market and the growth strategies adopted by the market players to sustain in the fast

Analyzing historical market, estimation of the current market and forecasting the future market for Global In-Vitro Diagnostics were the three major steps undertaken to create and analyze the overall adoption of in-vitro diagnostic services in major regions/countries. Exhaustive secondary research was conducted to collect the historical market of the technology and overall estimation of the current market. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted with industry experts across value chain of the In-Vitro Diagnostics technology. Post assumption and validation of market numbers through primary interviews, top-down approach was employed to forecast the complete market size of In-Vitro Diagnostics market globally. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the overall market size of segments and sub-segments of the technology. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the Global In-Vitro Diagnostics Market through company internal sources such as annual report & financial statements, performance presentations, press releases, inventory records, etc. and external sources including trade journals, news & articles, government publications, economic data, competitor publications, sector reports, regulatory bodies publications, safety standard organizations, third-party database and other credible publications. For economic data collection, sources such as World Bank, CDC, European Commission (EC), United Nations and WHO, OECD among others were used.

Step 2: Market Segmentation:

After obtaining the historical market size of the overall market, detailed secondary analysis was conducted to gather historical market insights and share for different segments and sub-segments of the Global In-Vitro Diagnostics technology. Major segments included in the report are product, techniques, applications, end-users and usability.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments detailed factor analysis was conducted to estimate the current market size of the Global In-Vitro Diagnostics technology. Factor analysis was conducted using dependent and independent variables such as accelerating aging population, rising prevalence of age-related disorders and Increasing demand for residential care facilities. Historical trends of the Global In-Vitro Diagnostics technology and their year-on-year impact on the market size and share in the recent past were analyzed. The demand and supply-side scenario were also thoroughly studied.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at current market size, key players in major applications and markets, market shares of these players and industry’s supply chain. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weightage was assigned to different factors including market drivers, restraints, opportunities and trends. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up/Top-down was applied to arrive at the market forecast pertaining to 2025 for different segments and sub-segments of the technology. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value and rate of adoption of In-Vitro Diagnostics globally
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in major applications and markets as well as the market share of each player. Also, the growth strategies adopted by these players to compete in the ever-growing Global In-Vitro Diagnostics market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, etc.). Primary research findings were summarised, and statistical analysis was performed to prove the stated hypothesis. Input from primary research was consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants

Market Engineering

Data triangulation technique was employed to complete the overall market engineering process and to arrive precise statistical numbers of each segment and sub-segment pertaining to the Global In-Vitro Diagnostics market. Data was split into several segments post studying various parameters and trends in areas such as product, techniques, applications, end-user, usability and regions such as North America, Europe, Asia-Pacific and Rest of the World.

Main objective of the In-Vitro Diagnostics Market Study

The current & future market trends of the Global In-Vitro Diagnostics market are pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market, providing a platform for the industrial participant to exploit the untapped market to benefit as first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the global in-vitro diagnostics market in terms of value (US$)
  • Analyze the current and forecast market size of different segments and sub-segments of the global in-vitro diagnostics market
  • To analyze the revenue and business models of the market players in the industry
  • To understand the initiatives undertaken by diagnostics companies Vs. service providers to increase the overall analysis of in-vitro diagnostics in major regions
  • Define and describe the segments and sub-segments considered in the evaluation of the global in-vitro diagnostics market and anticipate potential risk associated with the market
  • Define and analysis of the government regulations for diagnostics
  • Analyze the current and forecast market size of the global in-vitro diagnostics market for major regions/countries including North America (US, Canada, Rest of North of America), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific) and Rest of World (Brazil, Others)

Define and analyze the competitive landscape of the global in-vitro diagnostics market and the growth strategies adopted by the market players to sustain in the fast


In-Vitro Diagnostics Market: Current Scenario and Forecast (2019-2025)